Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Asimus

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
British Journal of Clinical Pharmacology|May 19, 2007
Retrospective analysis of artemisinin pharmacokinetics: application of a semiphysiological autoinduction modelSara Asimus, Toufigh Gordi
Biopharmaceutics & Drug Disposition|June 30, 2009
Artemisinin--a possible CYP2B6 probe substrate?Sara Asimus, Michael Ashton
European Journal of Clinical Pharmacology|December 8, 2007
Artemisinin and CYP2A6 activity in healthy subjectsSara Asimus, Trinh Ngoc Hai, Nguyen Van Huong, et al.
BMJ Open Respiratory Research|March 3, 2016
Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848Stephen Delaney, Mark Biffen, Justine Maltby, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 18, 2018
AZD7624, an Inhaled p38 Inhibitor, Demonstrates Local Lung Inhibition of LPS-Induced TNF<i>α</i> with Minimal Systemic ExposureRikard Pehrson, Tove Hegelund-Myrbäck, Danen Cunoosamy, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
PXR variants and artemisinin use in Vietnamese subjects: frequency distribution and impact on the interindividual variability of CYP3A induction by artemisininRita Piedade, Elke Schaeffeler, Stefan Winter, et al.
Fundamental & Clinical Pharmacology|May 25, 2007
Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjectsSara Asimus, Doaa Elsherbiny, Trinh N Hai, et al.
British Journal of Clinical Pharmacology|February 19, 2020
Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid-related orphan receptor γ agonist AZD0284Sara Asimus, Robert Palmér, Muna Albayaty, et al.
Clinical Chemistry|October 24, 2007
The Vietnamese Khin population harbors particular N-acetyltransferase 2 allele frequenciesIsa Cavaco, Sara Asimus, Myriam Peyrard-Janvid, et al.
Respiratory Medicine|December 8, 2021
Diurnal variation in DLCO and non-standardized study procedures may cause a false positive safety signal in clinical trialsKrishna Tulasi Kirla, Szilárd Nemes, Joanne Betts, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
British Journal of Clinical Pharmacology|May 19, 2007
Retrospective analysis of artemisinin pharmacokinetics: application of a semiphysiological autoinduction modelSara Asimus, Toufigh Gordi
Biopharmaceutics & Drug Disposition|June 30, 2009
Artemisinin--a possible CYP2B6 probe substrate?Sara Asimus, Michael Ashton
European Journal of Clinical Pharmacology|December 8, 2007
Artemisinin and CYP2A6 activity in healthy subjectsSara Asimus, Trinh Ngoc Hai, Nguyen Van Huong, et al.
BMJ Open Respiratory Research|March 3, 2016
Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848Stephen Delaney, Mark Biffen, Justine Maltby, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 18, 2018
AZD7624, an Inhaled p38 Inhibitor, Demonstrates Local Lung Inhibition of LPS-Induced TNF<i>α</i> with Minimal Systemic ExposureRikard Pehrson, Tove Hegelund-Myrbäck, Danen Cunoosamy, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
PXR variants and artemisinin use in Vietnamese subjects: frequency distribution and impact on the interindividual variability of CYP3A induction by artemisininRita Piedade, Elke Schaeffeler, Stefan Winter, et al.
Fundamental & Clinical Pharmacology|May 25, 2007
Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjectsSara Asimus, Doaa Elsherbiny, Trinh N Hai, et al.
British Journal of Clinical Pharmacology|February 19, 2020
Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid-related orphan receptor γ agonist AZD0284Sara Asimus, Robert Palmér, Muna Albayaty, et al.
Clinical Chemistry|October 24, 2007
The Vietnamese Khin population harbors particular N-acetyltransferase 2 allele frequenciesIsa Cavaco, Sara Asimus, Myriam Peyrard-Janvid, et al.
Respiratory Medicine|December 8, 2021
Diurnal variation in DLCO and non-standardized study procedures may cause a false positive safety signal in clinical trialsKrishna Tulasi Kirla, Szilárd Nemes, Joanne Betts, et al.
Pageof 2